Hoag SW - Search Results

1

The impact of diluents on the compaction, dissolution, and physical stability of amorphous solid dispersion tablets.

Yu D, Hoag SW. Yu D, et al. Among authors: hoag sw. Int J Pharm. 2024 Apr 10;654:123924. doi: 10.1016/j.ijpharm.2024.123924. Epub 2024 Feb 22. Int J Pharm. 2024. PMID: 38395318

2

Comprehensive evaluation of polymer types and ratios in Spray-Dried Dispersions: Compaction, Dissolution, and physical stability.

Yu D, Nie H, Hoag SW. Yu D, et al. Among authors: hoag sw. Int J Pharm. 2024 Jan 25;650:123674. doi: 10.1016/j.ijpharm.2023.123674. Epub 2023 Dec 5. Int J Pharm. 2024. PMID: 38061497

3

Development and Validation of a Stability-indicating UPLC-DAD Method for the Simultaneous Determination of Ivermectin and Praziquantel in Pharmaceutical Tablets and Dissolution Media.

Ibrahim A, Wang F, Gary Hollenbeck R, Martinez MN, Fahmy R, Hoag SW. Ibrahim A, et al. Among authors: hoag sw. AAPS PharmSciTech. 2023 Oct 11;24(7):211. doi: 10.1208/s12249-023-02656-y. AAPS PharmSciTech. 2023. PMID: 37821763

4

ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative.

Kagan AB, Moses BS, Lapidus R, Mott BT, Rai G, Anders NM, Hoag SW, Rudek MA, Civin CI. Kagan AB, et al. Among authors: hoag sw. Cancer Chemother Pharmacol. 2023 Jul;92(1):39-50. doi: 10.1007/s00280-023-04539-2. Epub 2023 May 30. Cancer Chemother Pharmacol. 2023. PMID: 37249624

5

Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical Trial.

Belcher AM, Cole TO, Massey E, Billing AS, Wagner M, Wooten W, Epstein DH, Hoag SW, Wickwire EM, Greenblatt AD, Colloca L, Rotrosen J, Magder L, Weintraub E, Wish ED, Kaptchuk TJ. Belcher AM, et al. Among authors: hoag sw. JAMA Netw Open. 2023 Apr 3;6(4):e237099. doi: 10.1001/jamanetworkopen.2023.7099. JAMA Netw Open. 2023. PMID: 37043203 Free PMC article. Clinical Trial.

6

Delivery of a therapeutic antibody to the lower gastrointestinal tract for the treatment of Clostridium difficile infection (CDI).

Jiang B, Yu D, Zhang Y, Hamza T, Feng H, Hoag SW. Jiang B, et al. Among authors: hoag sw. Pharm Dev Technol. 2023 Feb;28(2):232-239. doi: 10.1080/10837450.2023.2174553. Epub 2023 Feb 17. Pharm Dev Technol. 2023. PMID: 36789978

7

Surface Characterization as a Tool for Identifying the Factors Affecting the Dissolution Rate of Amorphous Solid Dispersion Tablets.

Yu D, Fiddler F, Ibrahim A, Sanedrin R, Tremblay H, Hoag SW. Yu D, et al. Among authors: hoag sw. AAPS PharmSciTech. 2022 Oct 17;23(8):282. doi: 10.1208/s12249-022-02413-7. AAPS PharmSciTech. 2022. PMID: 36253562

8

Formulation of smokeless tobacco products with a wide range of pH to study nicotine pharmacokinetics and pharmacodynamics.

Hoag SW, Mishina EV, Viray L, Wang F, Hollenbeck G, Koszowski B, Pickworth WB. Hoag SW, et al. Pharm Dev Technol. 2022 Jul;27(6):646-653. doi: 10.1080/10837450.2022.2102650. Epub 2022 Jul 27. Pharm Dev Technol. 2022. PMID: 35850567

9

A method for the tribological assessment of oral pharmaceutical liquids.

Lee HJ, Hollenbeck RG, Morgan JA, Kruger Howard A, Siddiqui A, Sayeed VA, Selen A, Hoag SW. Lee HJ, et al. Among authors: hoag sw. Drug Dev Ind Pharm. 2022 May;48(5):198-210. doi: 10.1080/03639045.2022.2092125. Epub 2022 Aug 16. Drug Dev Ind Pharm. 2022. PMID: 35726510

10

Lack of an Effect of Polysorbate 80 on Intestinal Drug Permeability in Humans.

Metry M, Krug SA, Karra VK, Ekins S, Hoag SW, Kane MA, Fink JC, Polli JE. Metry M, et al. Among authors: hoag sw. Pharm Res. 2022 Aug;39(8):1881-1890. doi: 10.1007/s11095-022-03312-z. Epub 2022 Jun 8. Pharm Res. 2022. PMID: 35672541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page